Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

XSSC:688076 Stock Report

Market Cap: CN¥12.0b

Jiangsu Sinopep-Allsino Biopharmaceutical Future Growth

Future criteria checks 6/6

Jiangsu Sinopep-Allsino Biopharmaceutical is forecast to grow earnings and revenue by 31.4% and 31.5% per annum respectively. EPS is expected to grow by 32.2% per annum. Return on equity is forecast to be 23.1% in 3 years.

Key information

31.4%

Earnings growth rate

32.2%

EPS growth rate

Pharmaceuticals earnings growth18.3%
Revenue growth rate31.5%
Future return on equity23.1%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:688076 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,1848206707015
12/31/20252,382601-1544935
12/31/20241,774439-3733275
9/30/20241,576421-495382N/A
6/30/20241,464348-365376N/A
3/31/20241,181208-445284N/A
12/31/20231,034163-310350N/A
9/30/2023979168-271280N/A
6/30/2023784136-244217N/A
3/31/2023725134-218173N/A
12/31/2022651129-40929N/A
9/30/202257695-34933N/A
6/30/202260399-30780N/A
3/31/202261292-169168N/A
12/31/2021644115-53181N/A
9/30/2021642113-34173N/A
6/30/2021660126116245N/A
3/31/202168715954165N/A
12/31/202056712330141N/A
9/30/202048194-24104N/A
6/30/202042574-13165N/A
3/31/202035346-17766N/A
12/31/201937249-23046N/A
9/30/201931340-22090N/A
6/30/201926631-20562N/A
3/31/201929859-19843N/A
12/31/201825644-10196N/A
9/30/201828466-13723N/A
6/30/201828671N/A-43N/A
3/31/201824546N/A40N/A
12/31/201722942N/A11N/A
9/30/2017156-7N/A51N/A
6/30/2017104-46N/A78N/A
3/31/201726-66N/A-4N/A
12/31/20169-75N/A-22N/A
9/30/20166-53N/A-79N/A
6/30/20163-33N/A-137N/A
3/31/20166-32N/A-125N/A
12/31/20159-30N/A-113N/A
12/31/2014N/A-25N/A68N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688076's forecast earnings growth (31.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 688076's earnings (31.4% per year) are forecast to grow faster than the CN market (26.1% per year).

High Growth Earnings: 688076's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688076's revenue (31.5% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 688076's revenue (31.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688076's Return on Equity is forecast to be high in 3 years time (23.1%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y